Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for hodgkin’s disease

Sandra Snider, Rifaat Bashir, Philip Bierman

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

We analyzed 168 consecutive patients with Hodgkinx0027;s disease who were treated at the University of Nebraska Medical Center between 1985 and 1990 with high-dose chemotherapy followed by autologous bone marrow transplantation (BMT) or peripheral stem-cell transplantation (PSCT), and describe their neurologic complications. All these patients had relapsed or had failed to achieve a remission with initial chemotherapy. Early complications, defined as those occurring during the first 6 weeks following the transplantation, occurred in 65 patients (39%) and included encephalopathy, seizures, psychiatric symptoms, and cerebral hemorrhage; these were mild and reversible in 47 and fatal in 18 patients. The major cause of these early neurologic complications was pulmonary failure. Late neurologic complications, defined as those occurring 6 weeks after the BMT or PSCT was performed, occurred in 21% of patients and included encephalopathy, peripheral neuropathy, cerebral hemorrhage, and spinal cord compression. Serious nervous system complications following autologous BMT or PSCT for Hodgkinx0027;s disease are less frequent than those following allogeneic BMT and are usually a result of injury to other organ systems.

Original languageEnglish (US)
Pages (from-to)681-684
Number of pages4
JournalNeurology
Volume44
Issue number4
DOIs
StatePublished - Apr 1994

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for hodgkin’s disease'. Together they form a unique fingerprint.

Cite this